Rapid clinical improvement of refractory subacute cutaneous lupus erythematosus with oral tyrosine kinase 2 inhibitor deucravacitinib: A case report.
B KurzI IvanovaK DrexlerM BerneburgF GüntherDennis NiebelPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)